Dipl. Ing. Martin Piskáček, Dr. rer. nat.
Head of the research group, Martin Piskáček Group: Transcription in Malignant Cells and Immunity
Office: bldg. C03/338
Kamenice 753/5
625 00 Brno
Phone: | +420 549 49 6697 |
---|---|
E‑mail: |
social and academic networks: |
---|
Total number of publications: 40
2022
-
Plasma levels of immune checkpoint inhibitor ligands PD-L1, B7-H3 and galectin-9 in glioblastoma patients
Year: 2022, type: Conference abstract
-
Tumor infiltration of gamma-delta T cells in glioblastoma
Year: 2022, type: Conference abstract
2021
-
Blocking of EphA2 on Endometrial Tumor Cells Reduces Susceptibility to Vδ1 Gamma-Delta T-Cell-Mediated Killing
Frontiers in Immunology, year: 2021, volume: 12, edition: October 2021, DOI
-
Gamma-delta T cells in Glioblastoma patients
Year: 2021, type: Conference abstract
-
Gamma-delta T cells in Glioblastoma patients
Year: 2021, type:
-
Infiltration of Gamma-delta T cells into Glioblastoma Tumor
Year: 2021, type: Conference abstract
-
Plasmacytoid Dendritic Cells in Patients with MGUS and Multiple Myeloma
Journal of Clinical Medicine, year: 2021, volume: 10, edition: 16, DOI
-
The 9aaTAD Activation Domains in the Yamanaka Transcription Factors Oct4, Sox2, Myc, and Klf4
Stem Cell Reviews and Reports, year: 2021, volume: 17, edition: 5, DOI
-
Úloha cytotoxických gamma-delta T buněk na terapeutické rezistenci a recidivě Glioblastoma Multiforme
Year: 2021, type: Conference abstract
-
Úloha cytotoxických gamma-delta T buněk na terapeutické rezistenci a recidivě Glioblastoma Multiforme
Year: 2021, type: